A global phase III multicenter, randomized, double-arm, open label trial of ASP-1929 photoimmunotherapy versus physician's choice standard of care for the treatment of patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC)
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.